|
|
||||||||
Clinical Diabetes and Nutrition Section, National Institutes of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona 85016
Elevated plasma lipid and
nonesterified fatty acid concentrations reduce insulin-mediated glucose
disposal in skeletal muscle. Cultured myoblasts from 21 subjects were
studied for rates of palmitate oxidation and the effect of palmitate on
glycogen synthase activity at the end of an 18-h incubation in serum-
and glucose-free media. Oxidation rates of 40 µM palmitate in
cultured myoblasts correlated with the fasting glucose
(r = 0.71, P = 0.001), log fasting
insulin (r = 0.52, P = 0.03), and
insulin-mediated glucose storage rate (r =
0.50,
P = 0.04) of the muscle donors. Myoblast glycogen
synthase activity can be regulated by 240 µM palmitate, but the
changes are associated with the basal respiratory quotient and not with
the insulin resistance of the muscle donor. These results indicate that
myoblasts producing elevated palmitate oxidation rates in vitro can be
used to identify skeletal muscle abnormalities which are primary
contributors to insulin resistance in vivo. Effects of 240 µM
palmitate on myoblast glycogen synthase activity appear to be
mechanistically different from the relationship between myoblast
palmitate oxidation rates and insulin resistance of the muscle donor.
fatty acid oxidation; skeletal muscle; insulin resistance
This article has been cited by other articles:
![]() |
D. M. Mott, K. Stone, M. C. Gessel, J. C. Bunt, and C. Bogardus Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E444 - E450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |